Ticker: SLN

Company Overview: Silence Therapeutics plc (NASDAQ: SLN) is focused on developing RNA-based therapeutics targeting significant unmet medical needs, primarily in cardiovascular diseases, hematology, and rare diseases. The company operates a proprietary mRNAi GOLD™ platform, producing candidates ai...